Clinical Trial Update: Ketohexokinase Inhibition in Hereditary Fructose Intolerance [Phase 2]

View source ↗

Summary

Phase 2 trial update on ketohexokinase inhibition in hereditary fructose intolerance has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Fructose Intolerance

Snippet

Sponsor: Maastricht University Medical Center | Conditions: HFI | Phase 2 | Status: COMPLETED